Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK2850163 is a novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1α) which can inhibit RNase activity and IRE1α kinase activity (IC50s: 200 and 20 nM).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 15,000 | |||
10 mg | 在庫あり | ¥ 26,000 | |||
25 mg | 在庫あり | ¥ 55,000 | |||
50 mg | 在庫あり | ¥ 87,000 | |||
100 mg | 在庫あり | ¥ 130,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 16,000 |
ターゲット&IC50 | IRE1α RNase activity:200 nM , IRE1α kinase activity:20 nM |
分子量 | 446.41 |
分子式 | C24H29Cl2N3O |
CAS No. | 2121989-91-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 50 mg/mL (112.00 mM), Sonication is recommended.
DMSO: 67.5 mg/mL (151.21 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK2850163 2121989-91-9 Cell Cycle/Checkpoint IRE1 GSK 2850163 inhibit Inhibitor GSK-2850163 Inositol requiring enzyme 1 inhibitor